Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass UseReportar como inadecuado




Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Objective and Design

The soluble urokinase plasminogen activator receptor suPAR has been recently recognized as a potential biological marker of various disease states, but the impact of a major surgical intervention on the suPAR level has not yet been established. The aim of our study was to investigate if the induction of a systemic inflammatory reaction in response to cardiopulmonary bypass would be accompanied by an increase in the plasma suPAR level.

Methods and Subjects

Patients undergoing coronary artery bypass grafting under cardiopulmonary bypass CPB were added. Based on the baseline suPAR level, patients were divided into group 1 suPAR within normal range or group 2 suPAR above range. Blood was collected before the induction of anesthesia and 6 and 24 hours after surgery. Plasma suPAR, IL-6, IL-8, TNF-α, troponin I, NT-proBNP, and NGAL were quantified to assess the impact of surgical trauma on these markers.

Results

The baseline suPAR level was within the normal range in 31 patients 3.3 ng-mL, and elevated in 29 5.1 ng-mL p<0.001. Baseline mediators of systemic inflammatory reaction concentrations IL-6, TNF-α, and IL-8 and organ injury indices troponin I, NT-proBNP, and NGAL were low and increased after surgery in all patients p<0.05. The surgery did not cause significant changes in the suPAR level either at 6 or 24 hours after, however the difference between groups observed at baseline remained substantial during the postoperative period.

Conclusions

There was no change in the suPAR level observed in patients subjected to elective cardiac coronary artery bypass surgery and CPB, despite activation of a systemic inflammatory reaction.



Autor: Waldemar Gozdzik , Barbara Adamik, Anna Gozdzik, Maciej Rachwalik, Wojciech Kustrzycki, Andrzej Kübler

Fuente: http://plos.srce.hr/



DESCARGAR PDF




Documentos relacionados